0001209191-20-039726.txt : 20200701
0001209191-20-039726.hdr.sgml : 20200701
20200701161616
ACCESSION NUMBER: 0001209191-20-039726
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200701
DATE AS OF CHANGE: 20200701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Prener Anne
CENTRAL INDEX KEY: 0001797917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38822
FILM NUMBER: 201005533
MAIL ADDRESS:
STREET 1: C/O RUBIUS THERAPEUTICS
STREET 2: 399 BINNEY STREET SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kaleido Biosciences, Inc.
CENTRAL INDEX KEY: 0001751299
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 617-674-9000
MAIL ADDRESS:
STREET 1: 18 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-30
0
0001751299
Kaleido Biosciences, Inc.
KLDO
0001797917
Prener Anne
C/O KALEIDO BIOSCIENCES, INC.
65 HAYDEN AVENUE
LEXINGTON
MA
02421
1
0
0
0
Stock Option (Right to Buy)
7.43
2020-06-30
4
A
0
15000
0.00
A
2021-06-30
2030-06-29
Common Stock
15000
15000
D
/s/ Jerald Korn, Attorney-in-Fact
2020-07-01